يعرض 1 - 20 نتائج من 457 نتيجة بحث عن '"Holme, Pål A."', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
    Academic Journal

    المصدر: Reding , M T , Lalezari , S , Kenet , G , Di Minno , G , Ducore , J , Solms , A , Shah , A , Holme , P A , Poulsen , L H , Meijer , K , Simpson , M & Mancuso , M E 2024 , ' Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A : A Product Review ' , Drugs in R and D , vol. 24 , no. 3 , pp. 359-381 . https://doi.org/10.1007/s40268-024-00481-7

    وصف الملف: application/pdf

  14. 14
    Academic Journal
  15. 15
    Academic Journal

    المصدر: Holme , P A , Poulsen , L H , Tueckmantel , C , Maas Enriquez , M , Alvarez Román , M T & De Cristofaro , R 2024 , ' Safety and efficacy of damoctocog alfa pegol prophylaxis in patients with severe haemophilia A : Results of an interventional, post-marketing study ' , Haemophilia , vol. 30 , no. 2 , pp. 388-394 . https://doi.org/10.1111/hae.14930

  16. 16
    Academic Journal

    المصدر: 2040-6207.

    Relation: Ettingshausen, Carmen Escuriola Hermans, Cedric Holme, Pål Andre Cid, Ana R Khair, Kate Oldenburg, Johannes Négriér, Claude Botha, Jaco Lelli, Aurelia Windyga, Jerzy . Real-world data in patients with congenital hemophilia and inhibitors: final data from the FEIBA Global Outcome (FEIBA GO) study. Therapeutic Advances in Hematology (TAH). 2023; http://hdl.handle.net/10852/110568; 2260028; info:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Therapeutic Advances in Hematology (TAH)&rft.volume=&rft.spage=&rft.date=2023; Therapeutic Advances in Hematology (TAH); 14; https://doi.org/10.1177/20406207231184323

  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
  20. 20